{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:12:48Z","timestamp":1789398768002,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101055152"],"award-info":[{"award-number":["101055152"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101212927"],"award-info":[{"award-number":["101212927"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phrs.2026.108397","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:31:30Z","timestamp":1786721490000},"page":"108397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A universal cell-based method for high-throughput analysis of viroporin function and inhibition"],"prefix":"10.1016","volume":"231","author":[{"given":"Viktoria M.S.","family":"Kj\u00e6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-045X","authenticated-orcid":false,"given":"Felix","family":"Faas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo H.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-3254","authenticated-orcid":false,"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108397_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/infdis\/jiac296","article-title":"Prototype pathogen approach for vaccine and monoclonal antibody development: a critical component of the NIAID plan for pandemic preparedness","volume":"227","author":"Cassetti","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.phrs.2026.108397_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","article-title":"Viroporins","volume":"552","author":"Gonzalez","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2026.108397_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/bph.17317","article-title":"Advancing the field of viroporins\u2014structure, function and pharmacology: IUPHAR Review 39","author":"Devantier","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108397_bib4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"Embo J."},{"key":"10.1016\/j.phrs.2026.108397_bib5","doi-asserted-by":"crossref","first-page":"15219","DOI":"10.1021\/jacs.8b06741","article-title":"Inhibitors of the M2 proton channel engage and disrupt transmembrane networks of hydrogen-bonded waters","volume":"140","author":"Thomaston","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2026.108397_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011328","article-title":"Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2","volume":"19","author":"Ewart","year":"2023","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.phrs.2026.108397_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41422-021-00519-4","article-title":"SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target","volume":"31","author":"Xia","year":"2021","journal-title":"Cell. Res."},{"key":"10.1016\/j.phrs.2026.108397_bib8","article-title":"Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel","volume":"9","author":"Zhang","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.phrs.2026.108397_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(92)91239-Q","article-title":"The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers","volume":"190","author":"Duff","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.phrs.2026.108397_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00424-009-0760-1","article-title":"Solid-supported membrane technology for the investigation of the influenza A virus M2 channel activity","volume":"459","author":"Balannik","year":"2010","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.phrs.2026.108397_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep43487","article-title":"The Rotavirus NSP4 viroporin domain is a calcium-conducting ion channel","volume":"7","author":"Pham","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108397_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2007.05.001","article-title":"Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system","volume":"76","author":"StGelais","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.phrs.2026.108397_bib13","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fmolb.2024.1334819","article-title":"Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E","volume":"11","author":"Cubisino","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.108397_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0014-5793(02)03851-6","article-title":"The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine","volume":"535","author":"Griffin","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2026.108397_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01360-18","article-title":"Molecular characterization of the viroporin function of foot-and-mouth disease virus nonstructural protein 2B","volume":"92","author":"Gladue","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2026.108397_bib16","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1110\/ps.062730007","article-title":"Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein","volume":"16","author":"Torres","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.phrs.2026.108397_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads3071","article-title":"The SH protein of mumps virus is a druggable pentameric viroporin","volume":"11","author":"Devantier","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108397_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.phrs.2026.108397_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2006.05.028","article-title":"Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication","volume":"353","author":"Wilson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.phrs.2026.108397_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/acsmedchemlett.6b00311","article-title":"Affinity of rimantadine enantiomers against influenza A\/M2 protein revisited","volume":"8","author":"Drakopoulos","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108397_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi901799k","article-title":"Functional studies and modeling of pore-lining residue mutants of the influenza A Virus M2 Ion Channel","volume":"49","author":"Balannik","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2026.108397_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108397_bib23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s42003-021-02866-9","article-title":"Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro","volume":"4","author":"Toft-Bertelsen","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.phrs.2026.108397_bib24","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1093\/emboj\/16.12.3519","article-title":"Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release","volume":"16","author":"van Kuppeveld","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108397_bib25","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/jvi.70.10.7108-7115.1996","article-title":"The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels","volume":"70","author":"Ewart","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2026.108397_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(96)01146-5","article-title":"Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells","volume":"398","author":"Schubert","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2026.108397_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007548","article-title":"The effect of amantadine on an ion channel protein from Chikungunya virus","volume":"13","author":"Dey","year":"2019","journal-title":"PLOS Negl. Trop. Dis."},{"key":"10.1016\/j.phrs.2026.108397_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01425-18","article-title":"Influenza A Virus M2 protein apical targeting is required for efficient virus replication","volume":"92","author":"Wohlgemuth","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2026.108397_bib29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/prot.21642","article-title":"Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism","volume":"70","author":"Mehnert","year":"2008","journal-title":"Protein. Struct. Funct. Bioinforma."},{"key":"10.1016\/j.phrs.2026.108397_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01308-09","article-title":"Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages","volume":"54","author":"Khoury","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2026.108397_bib31","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"Griffin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2026.108397_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.692423","article-title":"Inhibition of SARS CoV envelope protein by flavonoids and classical viroporin inhibitors","volume":"12","author":"Breitinger","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.phrs.2026.108397_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s002490100177","article-title":"Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu","volume":"31","author":"Ewart","year":"2002","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.phrs.2026.108397_bib34","doi-asserted-by":"crossref","first-page":"46923","DOI":"10.1074\/jbc.M207847200","article-title":"Alphavirus 6K proteins form ion channels*","volume":"277","author":"Melton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108397_bib35","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"Pielak","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2026.108397_bib36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/cr.2011.112","article-title":"DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71","volume":"21","author":"Xie","year":"2011","journal-title":"Cell. Res."},{"key":"10.1016\/j.phrs.2026.108397_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.virol.2004.09.033","article-title":"SARS coronavirus E protein forms cation-selective ion channels","volume":"330","author":"Wilson","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.phrs.2026.108397_bib38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3390\/v14081750","article-title":"Searching for blockers of dengue and West Nile Virus Viroporins","volume":"14","author":"Lahiri","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.phrs.2026.108397_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/biomedicines10030641","article-title":"A potential viroporin: mutational study and drug repurposing","volume":"10","author":"Tomar","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108397_bib40","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1021\/acs.biochem.8b00721","article-title":"A Robust Proton Flux (pHlux) assay for studying the function and inhibition of the influenza A M2 proton channel","volume":"57","author":"Santner","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2026.108397_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1087057110396215","article-title":"Development and validation of a high-throughput screening assay for the hepatitis C Virus p7 Viroporin","volume":"16","author":"Gervais","year":"2011","journal-title":"SLAS Discov."},{"key":"10.1016\/j.phrs.2026.108397_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2144\/02323st05","article-title":"Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes","volume":"32","author":"Jespersen","year":"2002","journal-title":"BioTechniques"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:58:18Z","timestamp":1789397898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S1043661826003129"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108397","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A universal cell-based method for high-throughput analysis of viroporin function and inhibition","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108397"}}